What does Dr. NJ HENDRICKX do?

Dr. NJ HENDRICKX is a specialist medical practice in Kontich. Private Limited, started on 9 November 2017, 1 establishment.

What is the address of Dr. NJ HENDRICKX?

The registered office of Dr. NJ HENDRICKX is located at Mechelsesteenweg 238a, 2550 Kontich.

Is Dr. NJ HENDRICKX still active?

Yes. According to the CBE (18 September 2026) Dr. NJ HENDRICKX is active, legal situation “Normale toestand”, started on 9 November 2017.

Is Dr. NJ HENDRICKX registered on Peppol?

Yes, Dr. NJ HENDRICKX is registered on the Peppol network with ID 0208:0684561068.

What is the enterprise number of Dr. NJ HENDRICKX?

The enterprise number of Dr. NJ HENDRICKX is BE0684561068.

When was Dr. NJ HENDRICKX founded?

Dr. NJ HENDRICKX was founded on 9 November 2017.

Who are the directors of Dr. NJ HENDRICKX?

According to the 2025 annual accounts, the directors of Dr. NJ HENDRICKX are: Niels-Jan Hendrickx.

Is Dr. NJ HENDRICKX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 November 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. NJ HENDRICKX make in 2025?

Dr. NJ HENDRICKX posted a profit after taxes of € 282,160 in financial year 2025.

What is the revenue of Dr. NJ HENDRICKX?

As a small company, Dr. NJ HENDRICKX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 384,922.

Dr. NJ HENDRICKX (Private Limited) - Kontich

Dossier Dr. NJ HENDRICKX, printed on 18 September 2026 from databakkes.be/en/0684561068/dr-nj-hendrickx. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. NJ HENDRICKX from Kontich, company number BE0684561068, closed financial year 2025 with a result of € 282,160 after tax. For that financial year Dr. NJ HENDRICKX recorded a gross margin of € 384,922 and equity of € 20,405. Compared with financial year 2024, the result moved from € 306,918 to € 282,160. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.

What it is worth Healthy

€ 20,405

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 282,160

▼ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 286,046

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 282,160 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 81,409

▲ € 76,539 vs 2024

Of which on lease € 76,654.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 62,888

€ 12,796 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 1,357

▲ 261% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 355

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 134,489 Gross margin 2022: € 134,489 First fiscal year in the series	€ 225,481 Gross margin 2023: € 225,481 ▲ 68% vs 2022 (€ 134,489) Favourable step	€ 408,481 Gross margin 2024: € 408,481 ▲ 81% vs 2023 (€ 225,481) Favourable step	€ 384,922 Gross margin 2025: € 384,922 ▼ 6% vs 2024 (€ 408,481) Unfavourable step	▼ 6%
Profit after taxes	€ 102,676 Profit after taxes 2022: € 102,676 First fiscal year in the series	€ 170,090 Profit after taxes 2023: € 170,090 ▲ 66% vs 2022 (€ 102,676) Favourable step	€ 306,918 Profit after taxes 2024: € 306,918 ▲ 80% vs 2023 (€ 170,090) Favourable step	€ 282,160 Profit after taxes 2025: € 282,160 ▼ 8% vs 2024 (€ 306,918) Unfavourable step	▼ 8%
Equity	€ 28,108 Equity 2022: € 28,108 First fiscal year in the series	€ 28,093 Equity 2023: € 28,093 Unchanged (€ 28,108) Unfavourable step	€ 20,405 Equity 2024: € 20,405 ▼ 27% vs 2023 (€ 28,093) Unfavourable step	€ 20,405 Equity 2025: € 20,405 Unchanged (€ 20,405) Unchanged
Total debts	€ 134,249 Total debts 2022: € 134,249 First fiscal year in the series	€ 180,086 Total debts 2023: € 180,086 ▲ 34% vs 2022 (€ 134,249) Unfavourable step	€ 323,464 Total debts 2024: € 323,464 ▲ 80% vs 2023 (€ 180,086) Unfavourable step	€ 353,624 Total debts 2025: € 353,624 ▲ 9% vs 2024 (€ 323,464) Unfavourable step	▲ 9%
Cash	€ 145,021 Cash 2022: € 145,021 First fiscal year in the series	€ 191,895 Cash 2023: € 191,895 ▲ 32% vs 2022 (€ 145,021) Favourable step	€ 332,993 Cash 2024: € 332,993 ▲ 74% vs 2023 (€ 191,895) Favourable step	€ 286,046 Cash 2025: € 286,046 ▼ 14% vs 2024 (€ 332,993) Unfavourable step	▼ 14%
Retained profit	€ 9,558 Retained profit 2022: € 9,558 First fiscal year in the series	€ 9,543 Retained profit 2023: € 9,543 Unchanged (€ 9,558) Unfavourable step	€ 1,855 Retained profit 2024: € 1,855 ▼ 81% vs 2023 (€ 9,543) Unfavourable step	€ 1,855 Retained profit 2025: € 1,855 Unchanged (€ 1,855) Unchanged
Dividend	€ 109,500 Dividend 2022: € 109,500 First fiscal year in the series	€ 170,106 Dividend 2023: € 170,106 ▲ 55% vs 2022 (€ 109,500) Unchanged	€ 314,606 Dividend 2024: € 314,606 ▲ 85% vs 2023 (€ 170,106) Unchanged	€ 282,160 Dividend 2025: € 282,160 ▼ 10% vs 2024 (€ 314,606) Unchanged	▼ 10%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 62,888 Bank debt 2025: € 62,888 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 162,357 Balance sheet total 2022: € 162,357 First fiscal year in the series	€ 208,179 Balance sheet total 2023: € 208,179 ▲ 28% vs 2022 (€ 162,357) Unchanged	€ 343,869 Balance sheet total 2024: € 343,869 ▲ 65% vs 2023 (€ 208,179) Unchanged	€ 374,029 Balance sheet total 2025: € 374,029 ▲ 9% vs 2024 (€ 343,869) Unchanged	▲ 9%

Key figures of Dr. NJ HENDRICKX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. NJ HENDRICKX?

What happened at Dr. NJ HENDRICKX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 28, 2026 New annual accounts for financial year 2025: profit of € 282,160 (▼ 8% vs 2024). Source: NBB ↗
Nov 9, 2017 New establishment in Kontich. KBO
2017 Niels-Jan Hendrickx became a director. NBB
Nov 9, 2017 Start of the company according to the CBE. KBO

In short

From € 102,676 profit in 2022 to € 282,160 profit in 2025.

Paid € 269,379 in corporate taxes since 2022.

Best year ever: 2024, with € 306,918 profit.

Paid out € 876,372 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. NJ HENDRICKX? We notify you, reason included.

Follow Dr. NJ HENDRICKX

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Niels-Jan Hendrickx

Dr. NJ HENDRICKX

Behind Dr. NJ HENDRICKX is Niels-Jan Hendrickx.

See the full network in the app

Directors

According to the 2025 annual accounts

Niels-Jan Hendrickx

Director

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Mechelsesteenweg 238a

2550 Kontich

2.269.856.814

Mechelsesteenweg 238 box a

2550 Kontich

Active since 9 November 2017

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0684.561.068
VAT number: BE 0684.561.068
Registered office: Mechelsesteenweg 238a, 2550 Kontich
Names & denominations: Dr. NJ HENDRICKX
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 November 2017
Peppol: Active · Active since 8 Feb 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗